Segall Bryant & Hamill’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $1.74M | Sell |
|
|||||
|
2023
Q1 | $1.88M | Sell |
|
|||||
|
2022
Q4 | $2.43M | Sell |
|
|||||
|
2022
Q3 | $4.83M | Sell |
|
|||||
|
2022
Q2 | $24.9M | Sell |
|
|||||
|
2022
Q1 | $44.7M | Sell |
|
|||||
|
2021
Q4 | $61.7M | Sell |
|
|||||
|
2021
Q3 | $69.3M | Sell |
|
|||||
|
2021
Q2 | $62.5M | Buy |
|
|||||
|
2021
Q1 | $39.1M | Buy |
|
|||||
|
2020
Q4 | $33M | Buy |
|
|||||
|
2020
Q3 | $23M | Buy |
|
|||||
|
2020
Q2 | $14.7M | Buy |
|